Advertisement
Screener

BeyondSpring Inc. (BYSI) Current Assets

2.8 / 5 stars · 68/120 Roast Me

BeyondSpring Inc. Current Assets

BeyondSpring Inc. (BYSI) had Current Assets of $9.90 million as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:AssetsCurrent · last filed 2026-08-14

  • 2026-06-30: Assets, Current $9.90M.
  • 2026-03-31: Assets, Current $13.50M.
  • 2025-12-31: Assets, Current $20.88M.
  • 2025-09-30: Assets, Current $24.41M.
Period endAssets, Current
2026-06-30$9.90M
10-Q · filed 2026-08-14
2026-03-31$13.50M
10-Q · filed 2026-05-13
2025-12-31$20.88M
10-Q · filed 2026-08-14
2025-09-30$24.41M
10-Q · filed 2025-11-12
2025-06-30$25.71M
10-Q · filed 2025-08-13
2025-03-31$31.53M
10-Q · filed 2025-05-12
2024-12-31$28.58M
10-K · filed 2026-03-25
2024-06-30$14.92M
6-K · filed 2024-08-29
2023-12-31$18.42M
10-K · filed 2025-03-27
2023-06-30$25.79M
6-K · filed 2024-02-02
2022-12-31$38.52M
6-K · filed 2024-02-02
2022-06-30$55.73M
6-K · filed 2023-02-28
2021-12-31$75.12M
20-F · filed 2023-04-18
2021-09-30$94.67M
6-K · filed 2021-12-30
2021-06-30$79.84M
6-K · filed 2021-09-10
2021-03-31$94.37M
6-K · filed 2021-06-16
2020-12-31$113.40M
20-F · filed 2022-04-14
2020-09-30$35.69M
6-K · filed 2020-11-17
2020-06-30$42.98M
6-K · filed 2020-09-03
2020-03-31$29.75M
6-K · filed 2020-06-11
2019-12-31$40.86M
20-F · filed 2021-04-30
2019-09-30$30.24M
6-K · filed 2019-12-18
2019-06-30$1.96M
6-K · filed 2019-09-18
2019-03-31$3.56M
6-K · filed 2019-07-10
2018-12-31$5.87M
20-F · filed 2020-04-30
2018-06-30$24.80M
6-K · filed 2018-10-23
2018-03-31$23.29M
6-K · filed 2018-06-21
2017-12-31$32.34M
20-F · filed 2019-04-30
2017-09-30$43.17M
6-K · filed 2017-11-09
2017-06-30$50.82M
6-K · filed 2017-08-21
2017-03-31$55.66M
6-K · filed 2017-05-22
2016-12-31$14.71M
20-F · filed 2018-04-03
2015-12-31$10.94M
20-F · filed 2017-04-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30